Literature DB >> 28105599

T1 mapping using saturation recovery single-shot acquisition at 3-tesla magnetic resonance imaging in hypertrophic cardiomyopathy: comparison to late gadolinium enhancement.

Ryo Ogawa1, Tomoyuki Kido2, Masashi Nakamura2, Teruhito Kido2, Akira Kurata2, Teruyoshi Uetani3, Akiyoshi Ogimoto3, Masao Miyagawa2, Teruhito Mochizuki2.   

Abstract

PURPOSE: We evaluated the T1 values of segments and slices and the reproducibility in healthy controls, using saturation recovery single-shot acquisition (SASHA) at 3T magnetic resonance imaging. Moreover, we examined the difference in T1 values between hypertrophic cardiomyopathy (HCM) and healthy controls, and compared those with late gadolinium enhancement (LGE).
MATERIALS AND METHODS: Twenty-one HCM patients and 10 healthy controls underwent T1 mapping before and after contrast administration. T1 values were measured in 12 segments.
RESULTS: Native T1 values were significantly longer in HCM than in healthy controls [1373 ms (1312-1452 ms) vs. 1279 ms (1229-1326 ms); p < 0.0001]. Even in HCM segments without LGE, native T1 values were significantly longer than in healthy control segments [1366 ms (1300-1439 ms) vs. 1279 ms (1229-1326 ms); p < 0.0001]. Using a cutoff value of 1327 ms for septal native T1 values, we differentiated between HCM and healthy controls with 95% sensitivity, 90% specificity, 94% accuracy, and an area under the curve of 0.95.
CONCLUSIONS: Native T1 values using a SASHA at 3T could differentiate HCM from healthy controls. Moreover, native T1 values have the potential to detect abnormal myocardium that cannot be identified adequately by LGE in HCM.

Entities:  

Keywords:  3-Tesla magnetic resonance imaging; Hypertrophic cardiomyopathy; Native T1; Saturation recovery single-shot acquisition; T1 mapping

Mesh:

Substances:

Year:  2017        PMID: 28105599     DOI: 10.1007/s11604-017-0611-5

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  34 in total

1.  Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution--reproducibility study.

Authors:  Daniel R Messroghli; Sven Plein; David M Higgins; Kevin Walters; Timothy R Jones; John P Ridgway; Mohan U Sivananthan
Journal:  Radiology       Date:  2006-01-19       Impact factor: 11.105

2.  The time for 3T clinical imaging is now.

Authors:  Marc D Shapiro; Tom Magee; David Williams; Rick Ramnath; Jeffrey S Ross
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

3.  T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Authors:  Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 7.792

4.  Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.

Authors:  Gil Moravsky; Efrat Ofek; Harry Rakowski; Jagdish Butany; Lynne Williams; Anthony Ralph-Edwards; Bernd J Wintersperger; Andrew Crean
Journal:  JACC Cardiovasc Imaging       Date:  2013-04-10

5.  Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction.

Authors:  Olaf Grebe; Ingo Paetsch; Hans A Kestler; Bernhard Herkommer; Bernhard Schnackenburg; Vinzenz Hombach; Eckart Fleck; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2003       Impact factor: 5.364

6.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Authors:  Valentina O Puntmann; Tobias Voigt; Zhong Chen; Manuel Mayr; Rashed Karim; Kawal Rhode; Ana Pastor; Gerald Carr-White; Reza Razavi; Tobias Schaeffter; Eike Nagel
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

7.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold.

Authors:  Stefan K Piechnik; Vanessa M Ferreira; Erica Dall'Armellina; Lowri E Cochlin; Andreas Greiser; Stefan Neubauer; Matthew D Robson
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-19       Impact factor: 5.364

8.  Standardization of T1 measurements with MOLLI in differentiation between health and disease--the ConSept study.

Authors:  Toby Rogers; Darius Dabir; Islam Mahmoud; Tobias Voigt; Tobias Schaeffter; Eike Nagel; Valentina O Puntmann
Journal:  J Cardiovasc Magn Reson       Date:  2013-09-11       Impact factor: 5.364

9.  Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study.

Authors:  Darius Dabir; Nicholas Child; Ashwin Kalra; Toby Rogers; Rolf Gebker; Andrew Jabbour; Sven Plein; Chung-Yao Yu; James Otton; Ananth Kidambi; Adam McDiarmid; David Broadbent; David M Higgins; Bernhard Schnackenburg; Lucy Foote; Ciara Cummins; Eike Nagel; Valentina O Puntmann
Journal:  J Cardiovasc Magn Reson       Date:  2014-10-21       Impact factor: 5.364

Review 10.  Native T1 mapping of the heart - a pictorial review.

Authors:  Philippe Germain; Soraya El Ghannudi; Mi-Young Jeung; Patrick Ohlmann; Eric Epailly; Catherine Roy; Afshin Gangi
Journal:  Clin Med Insights Cardiol       Date:  2014-12-01
View more
  2 in total

1.  Cardiac metastasis of neuroendocrine tumor of the thymus diagnosed by cardiac magnetic resonance T1 mapping: a case report.

Authors:  Jiamin Zhang; Mu Zeng
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 2.  Echocardiographic tissue imaging evaluation of myocardial characteristics and function in cardiomyopathies.

Authors:  Takahide Ito; Michihiro Suwa
Journal:  Heart Fail Rev       Date:  2021-07       Impact factor: 4.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.